IceCure Medical Ltd (ICCM) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery

Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization Decision

IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China

IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China PR Newswire CAESAREA, Israel...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America

IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule

IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price Rule PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]